Ron Baron Comments on Bio-Techne

Guru stock highlight

Author's Avatar
Nov 09, 2022
  • A top detractor.
Article's Main Image

Bio-Techne Corporation (

TECH, Financial) is a leading developer and manufacturer ofreagents, instruments, and services for the life sciences research, diagnostics, and bioprocessing markets. Short-term headwinds, including COVID-related lockdowns in China, foreign currency exchange rates, and some pull forward of sales into the prior quarter ahead of a price increase, pressured shares. We view these headwinds as temporary and continue to have conviction that Bio-Techne can generate strong long-term growth.


Ron Baron (Trades, Portfolio)'s Baron Growth Fund third-quarter 2022 commentary.

Also check out:


I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours. Click for the complete disclosure
0 / 5 (0 votes)
Author's Avatar

Request A Demo

Learn more about GuruFocus' key features, including All-In-One Screener, backtesting, 30-year financial, stock summary page, guru trades, insider trades, excel Add-in, google sheets and much more.

GuruFocus Screeners

Related Articles